PURPOSE OF REVIEW: T-cell interferon-gamma release assay (IGRA) use in tuberculosis (TB) contact screening and latent TB diagnosis is established and supported by American and European guidelines.

Gurgaon: The city leads in detecting tuberculosis (TB) cases in Haryana from 2023 to 2024 even as the aggregate TB cases in ...

Primary and secondary outcome measures The interferon-gamma release assay (IGRA) and the tuberculin skin test were used to detect LTBI. The IGRA result was used as a surrogate of LTBI in logistic ...

Kansas is currently dealing with a tuberculosis outbreak that is unprecedented in the U.S. What we know about Delaware's ...

Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...

Assays were performed following the manufacturer’s instructions and recommended ... In mild cases, FCER1A was significantly positively correlated with the expression of interferon gamma, IL-27, IL18, ...

Learn more about whether Qiagen N.V. or Repligen Corporation is a better investment based on AAII's A+ Investor grades, which ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Although they determined that other traditional epidemiologic risk factors for TB were not “significantly predictive,” other factors including positive interferon gamma release assay (OR = 6.7 ...

After hours: February 3 at 6:19:11 PM EST Loading Chart for QGEN ...